Smoothing Spline ANOVA (ANalysis Of VAriance) methods provide a exible alternative to the standard parametric GLIM (Generalized Linear Models) methods for analyzing the relationship of predictor variables to outcomes from data from large epidemiologic studies. These methods allow the visualization of relationships which are not readily t by simple GLIM models, and provide for the ability to visualize interactions between the variables, while at the same time they reduce to GLIM models if the data suggest that the added exibility is not warranted. Using this method, we investigate risk factors for incidence and progression of diabetic retinopathy in a group of patients with older onset diabetes from the Wisconsin Epidemiological Study of Diabetic Retinopathy. We carry out four analyses illustrating various properties of this class of methods. Some of the results con rm what has been previously found using standard methods, while others allow the visualization of more complex relationships not evident from the application of parametric methods.
INTRODUCTION
In many demographic medical studies, data of the form fy i ; t(i); i = 1; ng are collected, where i indexes the ith study participant, y i is 1 or 0 indicating whether some medical condition of interest at followup is present or absent, and t(i) = (t 1 (i); ; t d (i)) is a vector of d predictor variables at baseline, which may or may not be related to the likelihood that y i is a 1. From this data it is desired to estimate p(t) = Probfy = 1jtg, the probability that a person with predictor vector t will present the condition of interest at followup. Such estimates are used to estimate the prevalence of the condition of interest in general populations and to study the sensitivity of p to the predictor variables, or, if possible, to combinations of them. The traditional GLIM models 1] do this by de ning f(t), the logit, as f(t) = log p(t)=(1 ? p(t))] (1.1) and assuming that f is a simple parametric function of the components of t. When the t are continuous variables, the most commonly used model is linear in the components of t, f(t) = f(t 1 ; ; t d ) = + d X =1 t ; (1.2) but sometimes second or even third degree polynomials are used if it appears that a linear model may not be adequate. If some of the t are categorical variables, then indicator functions can be used. More generally, given M parametric functions ; = 1; ; M subject to some identi ability conditions, f is modeled parametrically as ( 1.4) with (1.2) or, more generally, (1.3), substituted in for f. If the`true but unknown' f is actually some linear combination of the speci ed then this is, of course the proper thing to do. Unfortunately, as large data sets are examined more closely, it becomes clear that linear models, or even quadratic or cubic models, may not be adequate. What happens if, for example, the dependence on t is "J" shaped, or, even has two peaks, possibly representing two distinct subpopulations? If the`true' log odds ratio f is not well approximated by some function of the speci ed form, then possibly large biases may be introduced in the estimates of f, furthermore, the common statistical hypothesis tests, con dence intervals, P-values and so forth are not necessarily valid if f is not of the speci ed form. The purpose of this paper is to describe and demonstrate the use of smoothing spline ANOVA (SS-ANOVA) methods for estimating f. These methods get around many of the above di culties, while providing the ability to visualize some of the relationships between the variables not easily observed via the use of more traditional methods. We will demonstrate their use to examine the relation of risk factors to the incidence and progression of diabetic retinopathy, using data from the Wisconsin Epidemiological Study of Diabetic Retinopathy (WESDR). The analysis here is based on (a special case of) the smoothing spline ANOVA method for modeling and estimating f which appears in Wahba, Wang, Gu, Klein and Klein 2](WWGKK), and we have implemented the analysis via the publicly available code GRKPACK described in Wang 3] . The code itself is available from netlib@research.att.com in the gcv directory there, and through statlib@lib.stat.cmu.edu.
An SS-ANOVA estimate is a form of penalized likelihood estimate. We rst note two important penalized likelihood estimates that appear in the literature. Then in the remainder of this introduction we describe the main features of SS-ANOVA in general and the details of the SS-ANOVA models in particular that we will be applying to the WESDR data. where the f are`smooth' functions obtained by some smoothing process, including the use of cubic smoothing splines. The S code (Chambers and Hastie 9]) provides the facility for tting models of the form (1.5). They also note that some of their work extends to the SS-ANOVA methods that we will be considering here. Cubic smoothing splines for the f in (1.5) are the solution to the minimization problem: Find f (in an appropriate function space), and subject to some identi ability criteria such as R f (t )dt = 0, to minimize the penalized log likelihood functional
where the penalty functionals J are de ned by
As the smoothing parameter tends to in nity, f tends to a linear function in t , so that the minimizer of (1.6) will tend to the linear function as in (1.2) if all the 's become large. Penalized likelihood methods with more general penalty functionals and unpenalized terms are discussed in 10]. Recent research has focussed on more general models for f which allow the explicit modeling and visualization of possible interactions between variables, via functional analysis of variance decompositions (to be described) and SS-ANOVA estimation methods. Given a fairly arbitrary function f(t 1 ; ; t d ) of several variables, a (functional) ANOVA decomposition of f may be de ned (generalizing ideas from parametric ANOVA) as As with any estimation method, it is important to have some indication of the accuracy of the method. It is particularly important in the case here of nonparametric regression with Bernoulli data obtained from medical records because this kind of data tends to be irregular, and may contain in uential outliers. The rigidity of parametric models may mask the e ect of outliers, as well as obscure the fact that inferences are sometimes made in fairly data sparse regions. The nonparametric estimates may be more sensitive to outliers, and it is important to be able to delineate a region in predictor variable space in which the estimate may be relied upon, as well as provide some sort of con dence statement. In this work we use the Bayesian`con dence intervals' proposed in 24], adapted to the component-wise multiple smoothing parameter case in 7] , to non-Gaussian data 25], and to the multiple smoothing parameter non-Gaussian case in 18] and WWGKK. The Bayesian`con dence interval' for f is used to delineate the region in predictor variable space for which the overall estimate is deemed to be reliable, by computing an appropriate level curve in a contour plot of the width of the con dence interval, and using this to enclose a`reliable' region. It is also used in conjunction with cross sectional plots so that the accuracy estimates can be visualized. The component-wise con dence intervals have been used to eliminate some terms which cannot be distinguished from noise, by deleting terms whose con dence intervals contain 0 over most of their domain. We remark that these con dence intervals are based on an across-thefunction property -that is, a 95% con dence interval has the property that, (approximately) the con dence intervals are expected to cover the true curve at about 95% of the n data points, see 25] 3] 20].
We now proceed to the details of the particular models that we will be employing in the analysis of the WESDR data. We will be analyzing four data sets, each of which illustrates some particular feature of this class of models. In each case the (continuous) predictor variables t 1 ; ; t d have been rescaled to 0; 1], and we will use the averaging operator E = E de ned in (1.9). We will only consider main e ects and two factor interactions. We will employ the penalty functional J of (1.7) and a two dimensional relative J to be de ned below. If all of the two factor interactions were eliminated, then the models described immediately below would reduce to the form (1.5) as studied by Hastie and Tibshirani, although our estimation method is di erent.
We need to make some de nitions in order to de ne the terms in the particular ANOVA decomposition (1.8) that we will be using. The two factor interaction f (t ; t ) has an analogous decomposition into four interaction terms, namely
where the`smooth' factors of the trend smooth interactions satisfy the side conditions ) and 6 smooth smooth parameters ( ), more than we would want to simultaneously t with the sample sizes here (all less than 500). The number of terms with smoothing parameters was reduced to a maximum of 7 based on previously published analyses of this data by more traditional methods, by extensive pre-screening by tting parametric polynomial GLIM models with terms as high as cubic order to detect and delete terms which did not give any evidence of signi cance, and by tting some marginal SS-ANOVA models as demonstrated in Section 6. More systematic pre-screening methods are an area of active research. Once the number of smoothing parameters was reduced to 7 or less, informal model selection methods as discussed in WWGKK were used, including the deletion of component terms which were too small to have an observable e ect on cross-sectional plots of f, and the deletion of terms whose component-wise con dence intervals included the 0 function. Further details speci c to each data set are given below. Leaving-out-one-third model selection procedures were discussed in 19], but have not been used here.
Section 2 discusses the Wisconsin Epidemiologic Study of Diabetic Retinopathy, and Sections 3, 4, 5 and 6 discuss the analysis of four data sets from this study. Section 7 is a summary and conclusion.
WISCONSIN EPIDEMIOLOGIC STUDY OF DIA-BETIC RETINOPATHY (WESDR)
The WESDR is an ongoing epidemiological study of a cohort of patients receiving their medical care in an 11-county area in southern Wisconsin, who were rst examined in . SS-ANOVA methods were applied to a subset of the data from the younger onset group in WWGKK in conjunction with an extensive technical account of the mathematical theory and numerical methods behind the method. It is the purpose of this account to carry out an SS-ANOVA analysis for four data sets from the older onset WESDR group,and in the process to illustrate some of the more important features of the method, with the goal of explaining the possible results, advantages and disadvantages in a less technical manner, aimed at an clinicians and medical researchers.
The present study is limited to building predictive models for incidence and for progression (to be de ned) of diabetic retinopathy at the rst followup, as a function of some of the covariates available at baseline. We will do this both for the \older onset group taking insulin" (ID group) and the \older onset group not taking insulin " (NID group). We will analyze for an`incidence event' and a`progression event' for both the ID and the NID groups. We only list the covariates pertinent to our analysis: 6. Baseline retinopathy severity levels (base-retinopathy-level). See explanation below.
At the baseline and follow-up examinations, each eye was graded as one of the 6 levels: 10, 21, 31, 41, 51 and 60+, in order of increasing retinopathy severity with 10 indicating no retinopathy and 60+ indicating the most severe stage, proliferative retinopathy. The retinopathy level for a participant was derived by giving the eye with the higher level (more severe retinopathy) greater weight. For example, the level for a participant with level 31 retinopathy in each eye is speci ed by the notation \level 31/31", whereas that for a participant with level 31 in one eye and less severe retinopathy in the other eye is noted as \level 31/<31". This scheme provided an 11-step scale: 10/10, 21/<21, 21/21, 31/<31, 31/31, 41/<41, 41/41, 51/<51, 51/51, 60+/<60+ and 60+/60+. Participants in the analysis for incidence consisted of subjects with level 10/10 at the baseline and no missing data, and the model will provide an estimate of the probability of incidence, which is de ned as the probability that such a participant has level 21/<21 or worse at the follow-up examination. Participants in the analysis for progression consisted of subjects with no or non-proliferative retinopathy at baseline and no missing data, and the model will provide an estimate of the probability of progression of such a participant, where progression is de ned as an increase in baseline level by two steps or more (10/10 to 21/21 or greater, or 21/<21 to 31/<31 or greater, for instance). These analyses correspond to analyses previously carried out by traditional methods in some of the WESDR references cited. Note that this allows subjects who are included in the analysis for incidence to also be part of the analysis for progression.
INCIDENCE IN THE OLDER ONSET GROUP NOT TAKING INSULIN
After excluding participants with missing values, there were 297 participants in the older onset NID group with a baseline score of 10/10, thus qualifying them for inclusion in the NID Incidence' analysis. One observation of glycosylated hemoglobin was recorded as 23.6%, which is much greater than the others. We decided to delete this in uential observation. Our conclusions remain the same with this observation in the analysis. Klein et al 26] found, using GLIM, that glycosylated hemoglobin is the only signi cant predictor of incidence of retinopathy in older onset patients. Using GLIM as a screening tool, we found that the e ect of age is not linear and that there is a strong interaction between age and glycosylated hemoglobin.
We rst t an SS-ANOVA model with the main e ects of age and glycosylated hemoglobin and all three interaction terms. The main e ect of glycosylated hemoglobin is linear. All interaction terms except trend(glycosylated hemoglobin) smooth(age) are near zero. The nal model is f(age, glycosylated hemoglobin) = + f 1 (age) + a 1 glycosylated hemoglobin + trend(glycosylated hemoglobin) smooth(age): (3.1)
We plot age vs glycosylated hemoglobin on left of Figure 3 .1. Those participants who had an incidence of retinopathy are marked as solid circles and those with no incidence are marked as open circles. We superimpose the contour lines of estimated posterior standard deviations. These contours agree well with the distribution of the observations. Thus they can be used to delineate a region in which the estimate of the probability function is deemed to be reliable. We decided to use the region with estimated posterior standard deviations less then or equal to 1, in the logit scale.
The probability function estimate is plotted on right of Figure 3 .1. Figure 3. 2 gives cross sections of the estimated probability of incidence as a function of age with the Bayesian con dence intervals at the cross sections, at four quantiles of glycosylated hemoglobin. The width of the con dence intervals suggests that the small bumps are probably an artifact, however the general shape of the response is evident, and it appears that the age e ect might not be particularly well modeled by a second or even third degree polynomial. The risk for incidence of retinopathy increases with increasing glycosylated hemoglobin. The risk increases with increasing age for lower glycosylated hemoglobin. This increase might be a result of development of other conditions such as hypertension and atherosclerotic vascular disease in older compared to younger subjects that lead to an increased risk of developing retinopathy even when the glycosylated hemoglobin level is relatively low. The risk decreases with increasing age for higher glycosylated hemoglobin. This decrease may be caused by mortality since an old participant with high glycosylated hemoglobin is more likely to die during the observation period.
PROGRESSION OF THE OLDER ONSET GROUP NOT TAKING INSULIN
After excluding participants with missing values, there were 432 participants in the older onset NID group quali ed to be included in the analysis for`Progression'. Klein et al 26] found that age, duration and glycosylated hemoglobin were signi cant in a GLIM model. Using GLIM, we found that the duration main e ect of polynomials up to the cubic is signi cant and the bmi main e ect of polynomials up to the quartic is signi cant. We also found that the multiplication interaction between age and polynomials up to cubic of duration is signi cant. These indicate that a GLIM with lower order polynomials may not The main e ects estimates and their Bayesian con dence intervals for glycosylated hemoglobin and bmi are plotted in Figure 4 .1. We see that the e ect of glycosylated hemoglobin is strong. The e ect of bmi is small, and 0 is contained within its con dence interval. The estimates are e ectively linear on a logit scale even though a`smooth' term for each of them was allowed in the model. This illustrates the ability of the method to reduce to a partially parametric form if that is warranted by the data.
The e ects of glycosylated hemoglobin and bmi are additive in the logit scale. In the remaining plots, we x glycosylated hemoglobin and bmi at their median values.
We plot age vs duration on the left of Figure 4 .2. Those participants who had progression of retinopathy are marked as solid circles and those with no progression are marked as open circles. We superimpose contour lines of the estimated posterior standard deviations as a function of age and duration with glycosylated hemoglobin and bmi xed at their median values. These contours agree well with the distribution of the observations. We decided to use the region with estimated posterior standard deviations less than or equal to 0.5. The probability function estimate is plotted on right of Figure 4 .2.
To see more clearly how the probability of progression depends on age and duration, we plot the cross sections of the estimate in Figure 4 see that the risk of progression of retinopathy decreases with increasing age and the shapes are di erent between the fourth quantile and other quantiles of duration. The risk increases with increasing duration up to about 17 years and does not increase after that. Increased mortality of those with longer duration and more severe retinopathy may explain, in part, this nding. Table 4 .1 gives the correspondence between the percentiles and the physical units. Figure 4 .2 indicate that participants who were diagnosed to have diabetes just above 30 years of age (points just below the dotted line in the left panel) are at higher risk of progression of their retinopathy than those diagnosed later in life.
INCIDENCE IN THE OLDER ONSET GROUP TAK-ING INSULIN
After excluding participants with missing data, there were 143 participants in the older onset ID group that had a baseline score of 10/10, and hence, are included in ID`Incidence' analysis. This sample size is probably not large enough to estimate interactions well. Klein et al 27] found that age and glycosylated hemoglobin are signi cant using a GLIM. We found that quadratic terms of duration and pulse are signi cant using a GLIM:
logit(p(age, duration, glycosylated hemoglobin, pulse)) = + a 1 age + a 2 duration + a 3 duration 2 + a 4 glycosylated hemoglobin + a 5 pulse + a 6 pulse 2 :
(5.1)
Fitting an SS-ANOVA model with main e ects of age, duration, glycosylated hemoglobin and pulse, we found that the main e ects of age and glycosylated hemoglobin are linear. Then we tted the model: f(age, duration, glycosylated hemoglobin, pulse) = + a 1 age + f 1 (duration) + a 2 glycosylated hemoglobin + f 2 (pulse):
The estimates of the main e ects and their 90% Bayesian con dence intervals are plotted in Figure 5 .1. We believe the ups and downs in the middle of the main e ect of duration are caused by the poor choice of the smoothing parameter (too small) due to the small sample size. But the pattern of the main e ect of duration is reliable and agrees with the previous conclusion. That is, the risk increases with the increasing duration up to about 6 years and does not increase any more thereafter. From the main e ect of pulse, we conclude that the risk is higher for participants with higher pulse rate. Higher resting pulse rate may be secondary to diabetic neuropathy involving the autonomic nervous system, a condition which has been postulated to be involved in the development of diabetic retinopathy. The ts from model (5.1) are well inside the Bayesian con dence intervals of the SS-ANOVA estimates. It is di cult to distinguish between these two models with such a small sample size. The quadratic form of the GLIM model for pulse is necessarily symmetric about its minimum at around 35 and suggests that the risk is increasing as pulse decreases below 35 while the SS-ANOVA model suggests that the minimum is a little higher, and the curve is attens out below its minimum.
The SS-ANOVA method needs relatively large sample sizes to get good estimates of multiple smoothing parameters. Our experience with real data and simulations suggest that about 100 observations for each smoothing parameter will give fairly reliable estimates.
PROGRESSION OF THE OLDER ONSET GROUP TAKING INSULIN
Due to its exibility, the SS-ANOVA method can be used in several stages of data analyses.
In the previous sections, we explained the SS-ANOVA method as a tool for model building and estimation. In practice, we can also use the SS-ANOVA method to explore the behavior of raw data. For example, we can get a marginal estimate for each covariate to investigate whether a covariate has a marginal nonlinear e ect. Alternatively, we can get some marginal estimates on pairs of 2 or more covariates to investigate their interactions. Furthermore, the SS-ANOVA method can be used as a diagnostic tool 35].
After deleting participants with missing data, there were 374 participants in the older onset ID group quali ed for inclusion in the analysis for`Progression'. Klein et al 26] found that age, duration, glycosylated hemoglobin and base-retinopathy-level are signicant using a GLIM model. They concluded that the risk of progression is higher if duration is longer and if base-retinopathy-level is lower (less severe). To investigate whether a GLIM is appropriate, we obtained SS-ANOVA estimates for age, duration, glycosylated hemoglobin and bmi separately. These marginal estimates and proportions within each decile on the logit scale are plotted in Figure 6 .1. Using GLIM, we nd that the e ect of age is nonlinear (signi cant up to 4th order of polynomials in a GLIM model). The e ect of bmi is borderline signi cant and nonlinear (a 4th order polynomial has a p value of 0.0609).
This data set provides an opportunity to include base-retinopathy-level as a categorical variable in the model. The estimates of the main e ects and their 90% Bayesian con dence intervals are plotted in Figure 6 1. The risk of progression of retinopathy increases with increasing duration of diabetes up to around 8 years and does not increase after that;
2. The e ect of body mass index is small; 3. Baseline level has a signi cant e ect on progression of retinopathy, but not monotonically. A subject with baseline level 10/10 has about same risk as a subject with baseline level 51/<51 or 51/51. A subject with baseline level 10/10 has higher risk than a subject with baseline level 31/<31 to 41/41. A subject with baseline level 10/10 has lower risk than a subject with baseline level 21/<21 or 21/21. This may re ect the arbitrary division of the levels which may not be evenly spaced, or, persons with more severe retinopathy may progress more rapidly but those who progress may be less likely to survive to be examined at the follow-up examination. 
CONCLUSIONS
We rst summarize the new ndings from our analyses, and then make some concluding remarks concerning the SS-ANOVA estimation methods.
1. Age e ects are nonlinear and di erent for di erent groups. For progression of the older onset ID group, the risk decreases with increasing age. Since mortality may change the population under study, especially for the older onset group, more frequent follow-up of a cohort (perhaps yearly) might provide further understanding of this relation.
2. The e ect of duration is consistent in all groups. The risk generally increases with increasing duration up to a certain point and does not increase after that. This indicates that if a person with older onset diabetes has not had an event (incidence or progression of retinopathy) after some years of diabetes, the risk will not substantially increase after that, although it remains higher than newly diagnosed persons.
3. The e ect of glycosylated hemoglobin is large, which agrees with previous studies. We nd that there is a strong interaction between age and glycosylated hemoglobin for incidence in the older onset NID group. 4 . The e ect of body mass index (bmi) is small.
5.
Pulse rate has a moderate e ect on the incidence of retinopathy in the older onset ID group. In a main e ects model which also included age, duration, and glycosylated hemoglobin , the main e ect for pulse rate is constant for lower pulse rates and then veers upward linearly (in the logit scale) for higher pulse rates. 6. Baseline retinopathy severity level (base-retinopathy-level) was found to have a signi cant e ect on progression in the older onset ID group in a main e ects model which also included age, duration, glycosylated hemoglobin and body mass index, but the e ect was not monotonic. Participants with baseline level 21/<21 and 21/21 had the highest risk and participants with baseline levels 31/<31 to 41/41 had the lowest risk of progression.
The SS-ANOVA models have provided us with a family of exible penalized log likelihood estimates, which speci cally include the possible tting of interaction terms, as well as allowing for combinations of continuous and categorical variates, which, moreover reduce to standard GLIM models as the smoothing parameters tend to in nity. These models are well adapted to the irregular distribution of multiple predictor variables commonly found in demographic data. The data-based method for estimating smoothing parameters allow the data to suggest when the exible or`smooth' components of the model are not necessary. This family of models allows the user to visualize complex relationships between variables that might not otherwise be evident from the use of purely parametric GLIM models. For example, the analysis here leads to new questions regarding why higher glycosylated hemoglobin in the younger subjects in the NID incidence group leads to increased risk compared to higher glycosylated hemoglobin in the older subjects in this group.
As with any nonparametric function estimation method, various assumptions about the function being estimated must be made. The primary assumption in the models of this paper is that f is`smooth' as measured by the integrals of ( @ 2 f @t 2 ) (which give the ve terms in the penalty functional of (1.12)).
There is a limit to the number of smoothing parameters that can be reliably estimated with the sample sizes here. Some of the local`wiggles' are probably a manifestation of that, particularly in Figure 5 .1. However, the Bayesian con dence intervals do suggest when bumps are not`real'. When used for exploratory purposes, the smoothing parameters chosen by the automatic method here may be used as starting guesses for`eyeball' or subjective smoothing parameter choices.
One drawback of this family of methods (aside from the fact that larger data sets are required than for standard purely parametric models) is the fact that the publicly available software for using them is not at the present time quite at the`cookbook' level. If a sample program for the particular model of interest is not available, the user must write a driver which contains details of their model. Examples of drivers for three models, including the one used in WWGKK, are packaged with GRKPACK. Drivers for the four SS-ANOVA models used in this paper may be obtained from the rst author. Since the GRKPACK code is based on matrix decompositions, it is relatively slow, and requires a relatively large amount of storage, placing an upper limit on the sample sizes can be analyzed. Approximate numerical methods that will reduce both the time and space required for a given sample size are an area of active research at the present time. In the meantime, we believe that the present methods represent an important new approach to the analysis of demographic data sets similar to those analyzed here.
